نتایج جستجو برای: non alcoholic cirrhosis

تعداد نتایج: 1359109  

2016
Akram Safaei Afsaneh Arefi Oskouie Seyed Reza Mohebbi Mostafa Rezaei-Tavirani Mohammad Mahboubi Maryam Peyvandi Farshad Okhovatian Mona Zamanian-Azodi

Metabolome analysis is used to evaluate the characteristics and interactions of low molecular weight metabolites under a specific set of conditions. In cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatotic hepatitis (NASH) the liver does not function thoroughly due to long-term damage. Unfortunately the early detection of cirrhosis, HCC, NAFL...

Journal: :Journal of hepatology 2016
Uttara Saran Bostjan Humar Philippe Kolly Jean-François Dufour

The majority of hepatocellular carcinoma occurs over pre-existing chronic liver diseases that share cirrhosis as an endpoint. In the last decade, a strong association between lifestyle and hepatocellular carcinoma has become evident. Abundance of energy-rich food and sedentary lifestyles have caused metabolic conditions such as obesity and diabetes mellitus to become global epidemics. Obesity a...

Journal: :The Journal of clinical investigation 2017
An-Ming Yang Tatsuo Inamine Katrin Hochrath Peng Chen Lirui Wang Cristina Llorente Sena Bluemel Phillipp Hartmann Jun Xu Yukinori Koyama Tatiana Kisseleva Manolito G Torralba Kelvin Moncera Karen Beeri Chien-Sheng Chen Kim Freese Claus Hellerbrand Serene Ml Lee Hal M Hoffman Wajahat Z Mehal Guadalupe Garcia-Tsao Ece A Mutlu Ali Keshavarzian Gordon D Brown Samuel B Ho Ramon Bataller Peter Stärkel Derrick E Fouts Bernd Schnabl

Chronic liver disease with cirrhosis is the 12th leading cause of death in the United States, and alcoholic liver disease accounts for approximately half of all cirrhosis deaths. Chronic alcohol consumption is associated with intestinal bacterial dysbiosis, yet we understand little about the contribution of intestinal fungi, or mycobiota, to alcoholic liver disease. Here we have demonstrated th...

2016
Jagtap Nitin Sharma Mithun Nageshwar Reddy

Abbreviations: HE: Hepatic Encephalopathy; PAMPs: Pathogen associated molecular patterns; TLRs: Toll-like Receptors; NLRs: Nodlike Receptors; LPS: Lipopolysacharide; HCV: Hepatitis C virus; CHB: Chronic Hepatitis B; HBV: Hepatitis B virus; ALD: Alcoholic Liver Disease; BM: Bone Marrow; NAFLD: Nonalcoholic Fatty Liver Disease; NASH: Non-alcoholic steatohepatitis; NO: Nitric Oxide; SIRS: Systemic...

Journal: :European review for medical and pharmacological sciences 2005
A Smedile E Bugianesi

The natural history of Non Alcoholic Fatty Liver Disease (NAFLD) is difficult to assess, but there is mounting evidence that patients with NAFLD may eventually develop cirrhosis and hepatocellular carcinoma (HCC). Retrospective, case-control studies have shown that features suggestive of Non Alcoholic SteatoHepatitis (NASH) are more frequent in HepatoCellular Carcinoma (HCC) complicating crypto...

2016
Abbas Tavakolian Arjmand Nasrin Razavianzadeh

Cirrhosis is defined as the advanced stages of hepatic fibrosis, with characteristic distortion of the hepatic architecture in addition to numerous regenerative nodules. Cirrhosis without an apparent cause is labeled cryptogenic (1, 2). Since metabolic syndrome was identified as a distinct medical entity, and insulin resistance and hyperinsulinemia have been addressed as its fundamental pathoph...

Journal: :Gut 1999
D Patch A Armonis C Sabin K Christopoulou L Greenslade A McCormick R Dick A K Burroughs

BACKGROUND Height of portal pressure correlates with severity of alcoholic cirrhosis. Portal pressure indices are not however used routinely as predictors of survival. AIMS To examine the clinical value of a single portal pressure measurement in predicting outcome in cirrhotic patients who have bled. METHODS A series of 105 cirrhotic patients who consecutively underwent hepatic venous press...

2008
Sophie Lotersztajn Henri Mondor

Introduction Chronic liver disease is responsible for about 800,000 deaths a year due to cirrhosis and its complications. The most common causes of liver disease worldwide are viral hepatitis, chronic alcohol consumption, and non-alcoholic fatty liver disease (NAFLD) associated with the metabolic syndrome. All these conditions generate liver injury and inflammation, thereby activating liver fib...

Journal: :Antimicrobial agents and chemotherapy 1984
C M MacLeod E A Bartley J A Payne E Hudes K Vernam R G Devlin

Aztreonam was administered as a single, 3-min, 1-g intravenous infusion to 18 subjects, including 6 with biopsy-proven, primary biliary cirrhosis, 6 with biopsy-proven, stable alcoholic cirrhosis, and 6 age- and sex-matched control subjects with normal hepatic functions. Aztreonam was well tolerated by all subjects. Multiple blood samples and timed, cumulative urine samples were taken for assay...

Journal: :Acta medica portuguesa 1981
P S Alves E A Camilo J P Correia

SUMMARY The SGOT/SGPT ratio has been estimated in 207 patients with alcoholic liver disease and in 3 control groups (43 viral hepatitis, 30 non-alcoholic chronic liver disease and 42 obstructive jaundice). The SGOT/SGTP ratio in alcoholic liver disease group was significantly higher (2.6 3 '± 1.82) than in any of the 3 control groups. If we consider the different alcoholic liver diseases the ra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید